Cytolytics GmbH
PrivateLast Round
Grant
Oct 30, 2024
Total Funding Raised
$549,000
Company Overview
Cytolytics GmbH operates in Healthcare & Life Sciences and is based in Tübingen. Its latest recorded funding round was a Grant round in October 2024.
Cytolytics GmbH is a medical technology company that provides an AI-based cloud software platform for the automated analysis of flow cytometry data for researchers and healthcare professionals.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytolytics GmbH Comparables
Compare Cytolytics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Miltenyi Biotec | 69% | |
| Danaher | 66% | |
| Sartorius Aktiengesellschaft | 62% |
For institutional investors. Book with your work email.
Cytolytics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 30, 2024 | ||||
| Grant | Sep 30, 2024 | ||||
| Pre Seed | Aug 16, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cytolytics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invest BW Innovationsförderung | Grant |
| State of Baden-Württemberg | Grant |
| L-Bank | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2024
$336K raised in grant funding.
- Oct 26, 2024
Monthly visitors grew 308% MoM, reaching 494.
For institutional investors. Book with your work email.
Cytolytics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cytolytics GmbH's valuation, stock price, and market status.
Is Cytolytics GmbH a public or private company?
Cytolytics GmbH is a private company.
What is the current stock price of Cytolytics GmbH?
Cytolytics GmbH is a private company, so its shares have no public market price. Caplight tracks Cytolytics GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cytolytics GmbH worth (valuation)?
Valuation information for Cytolytics GmbH is not publicly available.
Can I buy Cytolytics GmbH stock?
Cytolytics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cytolytics GmbH's last funding round?
Cytolytics GmbH's most recent funding round was Grant on October 30, 2024.
Who are the main investors in Cytolytics GmbH?
Key investors in Cytolytics GmbH include Invest BW Innovationsförderung, State of Baden-Württemberg, L-Bank.
Will Cytolytics GmbH IPO soon?
No public IPO plans have been announced for Cytolytics GmbH.
How can I track Cytolytics GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Cytolytics GmbH's shares on secondary markets.